Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Conditions
Interventions
Intervention1: Tab. Melatonin 3mg, once daily at night (HS), for 3 months duration: Tab. Melatonin 3mg, once daily at night (HS), for 3 months duration
Control Intervention1: Placebo: Placebo tablet f
Sponsors
KIMS Sunshine Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing primary TKA for osteoarthritis of the knee
Exclusion criteria
Exclusion criteria: Revision TKA, Unicompartmental TKA, History of substance abuse, previous history of any sleep disorders, previous history of anxiolytic of sleep medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality assessment using Epworth sleepiness score (ESS), Pittsburgh sleep quality index (PSQI), and PROMIS scoreTimepoint: 1 week, 2 weeks, 3 weeks, 4 weeks, 12 weeks post-surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse events or complications associated with Melatonin useTimepoint: 1 week, 2 weeks, 3 weeks, 4 weeks, 12 weeks post-surgery | — |
Countries
India
Contacts
Public ContactTarun Jayakumar
Sunshine Bone and Joint Institute, KIMS - Sunshine Hospitals
Outcome results
None listed